Real-World Experience of Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed or Refractory Aggressive B-cell Lymphomas: A Single-Institution Experience
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia December 2021 21(12):861-872 - Subject
- Language
- ISSN
- 2152-2650